BY 185
Latest Information Update: 11 Jul 1995
At a glance
- Originator ALTANA Pharma
- Class Antiulcers
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 11 Jul 1995 Discontinued-Preclinical for Peptic ulcer in Germany (Unknown route)